These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 1995729

  • 1. Immune responses to Bordetella pertussis infection and vaccination.
    Tomoda T, Ogura H, Kurashige T.
    J Infect Dis; 1991 Mar; 163(3):559-63. PubMed ID: 1995729
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
    Ausiello CM, Urbani F, La Sala A, Lande R, Piscitelli A, Cassone A.
    Dev Biol Stand; 1997 Mar; 89():315-20. PubMed ID: 9272365
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative safety and immunogenicity of an acellular versus whole-cell pertussis component of diphtheria-tetanus-pertussis vaccines in Senegalese infants.
    Simondon F, Yam A, Gagnepain JY, Wassilak S, Danve B, Cadoz M.
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):927-32. PubMed ID: 9031875
    [Abstract] [Full Text] [Related]

  • 6. Japanese clinical trials with Takeda acellular pertussis vaccine.
    Kuno-Sakai H, Kimura M, Ozaki K, Isomura S, Kamiya H, Nii R, Kato T, Horiuchi K, Syukuda Y, Fujita I.
    Tokai J Exp Clin Med; 1988 Dec; 13 Suppl():15-9. PubMed ID: 2908519
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Two primary doses of diphtheria-tetanus-acellular pertussis vaccine induce immunological responses to Bordetella pertussis as strong as those induced by three primary doses.
    Tomoda T, Ogura H, Kurashige T.
    Vaccine; 1997 Dec; 15(17-18):1955-8. PubMed ID: 9413107
    [Abstract] [Full Text] [Related]

  • 9. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
    Sato Y, Sato H.
    Dev Biol Stand; 1985 Dec; 61():367-72. PubMed ID: 3835079
    [Abstract] [Full Text] [Related]

  • 10. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
    Thomas MG, Ashworth LA, Miller E, Lambert HP.
    J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis.
    Roduit C, Bozzotti P, Mielcarek N, Lambert PH, del Giudice G, Locht C, Siegrist CA.
    Infect Immun; 2002 Jul; 70(7):3521-8. PubMed ID: 12065491
    [Abstract] [Full Text] [Related]

  • 13. Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis.
    Isacson J, Trollfors B, Hedvall G, Taranger J, Zackrisson G.
    Scand J Infect Dis; 1995 Jul; 27(3):273-7. PubMed ID: 8539553
    [Abstract] [Full Text] [Related]

  • 14. Serological responses to infection with B. pertussis.
    Giammanco A, Taormina S, Genovese M, Mangiaracina G, Giammanco G, Chiarini A.
    Dev Biol Stand; 1997 Jul; 89():213-20. PubMed ID: 9272353
    [Abstract] [Full Text] [Related]

  • 15. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
    Rastawicki W, Smietańska K, Rokosz-Chudziak N, Jagielski M.
    Med Dosw Mikrobiol; 2013 Jul; 65(4):269-74. PubMed ID: 24730215
    [Abstract] [Full Text] [Related]

  • 16. Effect of erythromycin treatment on antibody responses in pertussis.
    Granström G, Granström M.
    Scand J Infect Dis; 1994 Jul; 26(4):453-7. PubMed ID: 7984978
    [Abstract] [Full Text] [Related]

  • 17. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin, and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunized schoolchildren and adults.
    He Q, Tran Minh NN, Edelman K, Viljanen MK, Arvilommi H, Mertsola J.
    Infect Immun; 1998 Aug; 66(8):3796-801. PubMed ID: 9673264
    [Abstract] [Full Text] [Related]

  • 18. Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.
    Kwon HJ, Han SB, Kim BR, Kang KR, Huh DH, Choi GS, Ahn DH, Kang JH.
    BMC Infect Dis; 2017 Apr 04; 17(1):247. PubMed ID: 28376777
    [Abstract] [Full Text] [Related]

  • 19. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.
    Cherry JD, Gornbein J, Heininger U, Stehr K.
    Vaccine; 1998 Dec 04; 16(20):1901-6. PubMed ID: 9796041
    [Abstract] [Full Text] [Related]

  • 20. Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old.
    Halperin SA, Eastwood B, Barreto L, Mills E, Blatter M, Reisinger K, Bader G, Keyserling H, Roberts EA, Guasparini R.
    Scand J Infect Dis; 1995 Dec 04; 27(3):279-87. PubMed ID: 8539554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.